Report Update Nov 1, 2024

Norway - Medicaments Containing Hormones But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Norway: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Norway

In 2022, the Norwegian medicaments containing hormones market increased by X% to $X, rising for the third consecutive year after two years of decline. Over the period under review, consumption posted a strong expansion. Over the period under review, the market reached the peak level at $X in 2015; however, from 2016 to 2022, consumption failed to regain momentum.

Medicaments Containing Hormones Production in Norway

In value terms, medicaments containing hormones production reduced to $X in 2022 estimated in export price. Overall, production recorded a remarkable increase. The most prominent rate of growth was recorded in 2014 with an increase of X%. Over the period under review, production reached the peak level at $X in 2015; however, from 2016 to 2022, production stood at a somewhat lower figure.

Medicaments Containing Hormones Exports

Exports from Norway

In 2022, shipments abroad of medicaments containing hormones but not antibiotics decreased by X% to X kg, falling for the second consecutive year after three years of growth. Overall, exports saw a sharp slump. The pace of growth was the most pronounced in 2013 with an increase of X%. As a result, the exports reached the peak of X tons. From 2014 to 2022, the growth of the exports remained at a lower figure.

In value terms, medicaments containing hormones exports fell sharply to $X in 2022. In general, exports continue to indicate a sharp curtailment. The most prominent rate of growth was recorded in 2013 with an increase of X%. As a result, the exports reached the peak of $X. From 2014 to 2022, the growth of the exports failed to regain momentum.

Exports by Country

Sweden (X kg) was the main destination for medicaments containing hormones exports from Norway, with a approx. X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Sweden totaled X%.

In value terms, Sweden ($X) emerged as the key foreign market for medicaments containing hormones but not antibiotics exports from Norway.

From 2012 to 2022, the average annual growth rate of value to Sweden amounted to X%.

Export Prices by Country

The average medicaments containing hormones export price stood at $X per ton in 2022, which is down by X% against the previous year. In general, the export price showed a perceptible descent. The pace of growth was the most pronounced in 2015 when the average export price increased by X%. As a result, the export price attained the peak level of $X per ton. From 2016 to 2022, the average export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Sweden.

From 2012 to 2022, the rate of growth in terms of prices for Spain amounted to X% per year.

Medicaments Containing Hormones Imports

Imports into Norway

In 2022, purchases abroad of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the fifth consecutive year after two years of decline. Over the period under review, imports enjoyed a significant expansion. The pace of growth was the most pronounced in 2015 when imports increased by X% against the previous year. Over the period under review, imports attained the peak figure in 2022 and are likely to continue growth in years to come.

In value terms, medicaments containing hormones imports surged to $X in 2022. Overall, imports enjoyed a significant expansion. The most prominent rate of growth was recorded in 2018 when imports increased by X% against the previous year. Over the period under review, imports hit record highs in 2022 and are likely to see gradual growth in the near future.

Imports by Country

Poland (X tons), Denmark (X tons) and the UK (X kg) were the main suppliers of medicaments containing hormones imports to Norway, with a combined X% share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Denmark (with a CAGR of X%), while imports for the other leaders experienced mixed trend patterns.

In value terms, Denmark ($X), Poland ($X) and the UK ($X) appeared to be the largest medicaments containing hormones suppliers to Norway, together comprising X% of total imports.

Denmark, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average medicaments containing hormones import price amounted to $X per ton, rising by X% against the previous year. In general, the import price, however, continues to indicate a abrupt setback. The pace of growth was the most pronounced in 2014 when the average import price increased by X%. As a result, import price attained the peak level of $X,280 per ton. From 2015 to 2022, the average import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the UK ($X,070 per ton), while the price for Poland ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing hormones but not antibiotics in the world?

The country with the largest volume of medicaments containing hormones consumption was China, comprising approx. 18% of total volume. Moreover, medicaments containing hormones consumption in China exceeded the figures recorded by the second-largest consumer, India, twofold. The third position in this ranking was occupied by the United States, with a 5.3% share.

What are the largest producers of medicaments containing hormones but not antibiotics in the world?

China constituted the country with the largest volume of medicaments containing hormones production, accounting for 18% of total volume. Moreover, medicaments containing hormones production in China exceeded the figures recorded by the second-largest producer, India, twofold. The United States ranked third in terms of total production with a 5.3% share.

What are the leading suppliers of medicaments containing hormones but not antibiotics to Norway?

In value terms, Denmark constituted the largest supplier of medicaments containing hormones to Norway, comprising 48% of total imports. The second position in the ranking was occupied by Sweden, with an 18% share of total imports. It was followed by the UK, with a 12% share.

What are the leading importers of medicaments containing hormones but not antibiotics from Norway?

In value terms, Saudi Arabia remains the key foreign market for medicaments containing hormones exports from Norway.

What is the average export price for medicaments containing hormones but not antibiotics in Norway?

In 2021, the average medicaments containing hormones export price amounted to $75,458 per ton, falling by -16.6% against the previous year.

What is the average import price for medicaments containing hormones but not antibiotics in Norway?

In 2021, the average medicaments containing hormones import price amounted to $169,654 per ton, reducing by -18% against the previous year.

This report provides an in-depth analysis of the medicaments containing hormones market in Norway. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)

Country coverage:

Norway

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Norway
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023